Livmarli

maralixibat

Approval

ApplicationNDA 214662
Approval dateSep 29, 2021
Approval year2021
SponsorMirum

FDA-approved use

To treat cholestatic pruritus associated with Alagille syndrome

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Livmarli: